NYSE:RBOT Vicarious Surgical - RBOT Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. $2.46 +0.20 (+8.85%) (As of 03/21/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.30▼$2.4750-Day Range$2.24▼$3.5052-Week Range$1.69▼$6.00Volume175,429 shsAverage Volume297,157 shsMarket Capitalization$309.86 millionP/E Ratio82.00Dividend YieldN/APrice Target$6.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Vicarious Surgical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside143.9% Upside$6.00 Price TargetShort InterestBearish18.58% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$880,955 Bought Last QuarterProj. Earnings GrowthDecreasingFrom ($0.56) to ($0.64) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.24 out of 5 starsMedical Sector219th out of 983 stocksSurgical Appliances & Supplies Industry8th out of 23 stocks 3.5 Analyst's Opinion Consensus RatingVicarious Surgical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.00, Vicarious Surgical has a forecasted upside of 143.9% from its current price of $2.46.Amount of Analyst CoverageVicarious Surgical has received no research coverage in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted18.58% of the float of Vicarious Surgical has been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 12.6, which indicates bearish sentiment.Change versus previous monthShort interest in Vicarious Surgical has recently increased by 0.37%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RBOT. Previous Next 3.0 News and Social Media Coverage News SentimentVicarious Surgical has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.Search Interest27 people have searched for RBOT on MarketBeat in the last 30 days. This is an increase of 108% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have bought 333.27% more of their company's stock than they have sold. Specifically, they have bought $880,955.00 in company stock and sold $203,325.00 in company stock.Percentage Held by Insiders52.48% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.77% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Vicarious Surgical are expected to decrease in the coming year, from ($0.56) to ($0.64) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is 82.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.48.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is 82.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 147.48.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Vicarious Surgical (NYSE:RBOT) StockVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address RBOT Stock News HeadlinesMarch 15, 2023 | americanbankingnews.comVicarious Surgical Inc (NYSE:RBOT) Director Philip Liang Acquires 49,800 Shares of StockMarch 12, 2023 | americanbankingnews.comInsider Buying: Vicarious Surgical Inc (NYSE:RBOT) Director Acquires 37,100 Shares of StockMarch 22, 2023 | Investing Daily (Ad)This Trade Strategy Outpaces Almost AnythingDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. February 16, 2023 | finance.yahoo.comVicarious Surgical Inc. (NYSE:RBOT) Q4 2022 Earnings Call TranscriptFebruary 14, 2023 | bizjournals.comVicarious Surgical's shares pop following 14% workforce reductionFebruary 14, 2023 | msn.comVicarious Surgical rises after announcing layoffsFebruary 14, 2023 | finanznachrichten.deEncision, Inc.: Encision Signs Proof of Concept Agreement with Vicarious Surgical Inc.February 14, 2023 | finance.yahoo.comEncision Signs Proof of Concept Agreement with Vicarious Surgical Inc.March 22, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …February 13, 2023 | finance.yahoo.comVicarious Surgical Reports Fourth Quarter and Full Year 2022 Financial ResultsFebruary 10, 2023 | msn.comEarnings Preview: Vicarious SurgicalJanuary 30, 2023 | finance.yahoo.comVicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023December 22, 2022 | finance.yahoo.comVicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic SystemNovember 17, 2022 | finance.yahoo.comVicarious Surgical Partners with Renowned Surgeon to Successfully Perform Two Cadaveric Ventral Hernia ProceduresNovember 14, 2022 | finance.yahoo.comVicarious Surgical to Participate in Upcoming ConferencesNovember 10, 2022 | bizjournals.comPittsburgh CREATES in partnership with surgical firmNovember 10, 2022 | technews.tmcnet.comVicarious Surgical System Named to TIME's List of the Best Inventions of 2022November 10, 2022 | time.comOne Tiny IncisionNovember 10, 2022 | finance.yahoo.comVicarious Surgical System Named to TIME’s List of the Best Inventions of 2022November 8, 2022 | seekingalpha.comVicarious Surgical Inc. (RBOT) Q3 2022 Earnings Call TranscriptNovember 7, 2022 | finance.yahoo.comVicarious Surgical Reports Third Quarter 2022 Financial ResultsNovember 4, 2022 | msn.comEarnings Outlook For Vicarious SurgicalOctober 24, 2022 | finance.yahoo.comVicarious Surgical to Report Third Quarter 2022 Financial Results on November 7, 2022October 20, 2022 | finance.yahoo.comVicarious Surgical Announces Changes to Board of DirectorsOctober 15, 2022 | finance.yahoo.comWhile insiders own 21% of Vicarious Surgical Inc. (NYSE:RBOT), private equity firms are its largest shareholders with 28% ownershipOctober 13, 2022 | finance.yahoo.comVicarious Surgical Announces Upcoming Beta 2 Demonstration DaySeptember 3, 2022 | wsj.comVicarious Surgical Inc.See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address RBOT Company Calendar Last Earnings2/13/2023Today3/22/2023Next Earnings (Estimated)5/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/APrice Target and Rating Average Stock Price Forecast$6.00 High Stock Price Forecast$7.00 Low Stock Price Forecast$5.00 Forecasted Upside/Downside+143.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio82.00 Forward P/E RatioN/A P/E GrowthN/ANet Income$5.16 million Net MarginsN/A Pretax MarginN/A Return on Equity-65.98% Return on Assets-49.67% Debt Debt-to-Equity RatioN/A Current Ratio14.35 Quick Ratio14.35 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.88 per share Price / Book2.80Miscellaneous Outstanding Shares125,960,000Free Float59,854,000Market Cap$309.86 million OptionableOptionable Beta1.25 Key CompetitorsInogenNASDAQ:INGNSanara MedTechNASDAQ:SMTICollPlant BiotechnologiesNASDAQ:CLGNSutro BiopharmaNASDAQ:STROCara TherapeuticsNASDAQ:CARAView All CompetitorsInsiders & InstitutionsPhilip LiangBought 49,800 shares on 3/13/2023Total: $118,026.00 ($2.37/share)Philip LiangBought 37,100 shares on 3/9/2023Total: $92,750.00 ($2.50/share)William John KellySold 4,954 sharesTotal: $13,276.72 ($2.68/share)Philip LiangBought 30,000 shares on 3/2/2023Total: $78,000.00 ($2.60/share)June MorrisSold 2,500 sharesTotal: $7,025.00 ($2.81/share)View All Insider TransactionsView All Institutional Transactions RBOT Stock - Frequently Asked Questions Should I buy or sell Vicarious Surgical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RBOT shares. View RBOT analyst ratings or view top-rated stocks. What is Vicarious Surgical's stock price forecast for 2023? 1 brokers have issued twelve-month price objectives for Vicarious Surgical's stock. Their RBOT share price forecasts range from $5.00 to $7.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 143.9% from the stock's current price. View analysts price targets for RBOT or view top-rated stocks among Wall Street analysts. How have RBOT shares performed in 2023? Vicarious Surgical's stock was trading at $2.02 at the beginning of 2023. Since then, RBOT shares have increased by 21.8% and is now trading at $2.46. View the best growth stocks for 2023 here. When is Vicarious Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our RBOT earnings forecast. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) issued its quarterly earnings results on Monday, February, 13th. The company reported ($0.16) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.02. During the same quarter last year, the business earned ($0.15) earnings per share. What is Vicarious Surgical's stock symbol? Vicarious Surgical trades on the New York Stock Exchange (NYSE) under the ticker symbol "RBOT." Who are Vicarious Surgical's major shareholders? Vicarious Surgical's stock is owned by many different retail and institutional investors. Top institutional shareholders include MY.Alpha Management HK Advisors Ltd (2.49%), DDD Partners LLC (1.54%), Geode Capital Management LLC (0.68%), Jane Street Group LLC (0.43%), Charles Schwab Investment Management Inc. (0.27%) and Morgan Stanley (0.18%). Insiders that own company stock include Adam David Sachs, June Morris, Philip Liang, Sammy Khalifa and William John Kelly. View institutional ownership trends. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Vicarious Surgical's stock price today? One share of RBOT stock can currently be purchased for approximately $2.46. How much money does Vicarious Surgical make? Vicarious Surgical (NYSE:RBOT) has a market capitalization of $309.86 million. The company earns $5.16 million in net income (profit) each year or $0.03 on an earnings per share basis. How can I contact Vicarious Surgical? Vicarious Surgical's mailing address is 78 Fourth Avenue Waltham, MA 02451. The official website for the company is www.vicarioussurgical.com. The company can be reached via phone at 617 868 1700 or via email at ir@vicarioussurgical.com. This page (NYSE:RBOT) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.